English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Background  Stigma against the obese is well described in health care and may contribute to disparities in medical decision‐making. It is unknown whether similar disparity exists for obese patients in cardiovascular care. We evaluated the association between body mass index ( BMI ) and prescription of guideline‐recommended medications in patients undergoing elective percutaneous coronary intervention.    Methods and Results  Using data from the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program, we identified patients undergoing elective percutaneous coronary intervention from 2007 to 2012, stratifying them by category of  BMI . We described rates of prescription for class I guideline recommended medications for each  BMI  category (normal, overweight, and obese). Multivariable logistic regression assessed the association between  BMI  category and medication prescription. Seventeen thousand thirty‐seven patients were identified, with 35.3% having overweight  BMI , and 50.8% obese  BMI . Obese patients were more likely than normal  BMI  patients to be prescribed β‐blockers ( OR  1.34), statins ( OR  1.39), or  ACE / ARB  (odds ratio [ OR ] 1.52; all significant) when indicated. Overweight patients were more likely than normal  BMI  patients to be prescribed statins ( OR  1.29) and angiotensin‐converting enzymes/angiotensin  II  receptor blockers ( OR  1.41) when indicated. There was no association between  BMI  category and prescription of anticoagulants.    Conclusions  Over 85% of patients undergoing elective percutaneous coronary intervention in the Veterans Affairs are overweight or obese. Rates of guideline‐indicated medication prescription were <70% among all patients, and across  BMI  categories, with an association between increased  BMI  and greater use of guideline‐recommended medications. Our findings offer a possible contribution to the obesity paradox seen in many cardiovascular conditions.

journal of the american heart association

Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ( CART ) Program